Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Rifapentine

EU orphan designation number: EU/3/10/750   
Active ingredient: Rifapentine
Indication: Treatment of tuberculosis
Sponsor: Sanofi-Aventis groupe
54 rue La Boétie, F-75008 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Centralised Orphan - Designation EMEA/OD/145/09 (2010)3835 of 09/06/2010
06/11/2012 Orphan - Change name of sponsor EMEA/OD/145/09